Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Selective inhibitor of glycogen synthase kinase-3 stimulates glucose uptake in adipocytes

June 9, 2004

Mechanism of fluid retention by PPAR agonist GI-2570X

June 9, 2004

Agonistic antibodies to Epo receptors and their use as antianemic agents

June 8, 2004

The antidiabetic agent BLX-1002 subject of various presentations at ADA

June 8, 2004

Retinoid X receptor antagonist improves glucose and lipid metabolism in vivo

June 8, 2004

Vitamin C disappoints in diabetes study

June 8, 2004

Enrollment completed in phase IIb trial of AOD-9604 for obesity

June 8, 2004

New hypoglycemic agents developed by Yissum and Hadasit researchers

June 7, 2004

New bone resorption inhibitors targeting OCIF presented by Sankyo

June 7, 2004

Positive phase III results for Aryplase in MPS VI

June 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...